Is vaping 95% healthier than smoking?

That figure originated from an early review and has been widely quoted, but the evidence base is more complex and the true difference in long-term harm is uncertain. Below I explain where the 95% number came from, what later reviews and health bodies say, and how to interpret the statement sensibly — especially for Australian readers considering products such as alibarbar vape or the many disposable vapes Australia once widely sold.

Where did “95%” come from?

The widely cited “95% less harmful” estimate stems from a 2015 expert review and evidence update commissioned in the UK, which concluded that e-cigarettes were “around 95% less harmful” than combustible tobacco in terms of population-level harms. That figure was an expert judgement based on available data at the time.

Why that number is controversial

Two important points weaken confidence in any single percentage:

Limited long-term data. Most studies to date are short-term or observational. Long-term health outcomes from vaping (over decades) are not yet known, so precise quantification of risk relative to smoking is uncertain. Independent reviewers have cautioned against treating a single percentage as definitive.

Different methods, different estimates. Subsequent evidence reviews and position statements (from clinical and public-health bodies) note that while vaping is likely less harmful than smoking for many individual toxic exposures, the magnitude of that reduced harm varies by which outcomes you measure (respiratory, cardiovascular, cancer risk) and which device or liquid is used. Leading professional reviews therefore avoid repeating a fixed percentage without qualification.

What major health bodies say now

The Royal College of Physicians (UK) and some public-health reviews have recognised a role for e-cigarettes in smoking cessation while acknowledging uncertainty and the need for ongoing review.

Australian health authorities take a more cautious stance: vapes are not risk-free, and laws introduced in 2024/25 have tightened supply and framed nicotine vapes as medical/therapeutic products under strict controls. Australian guidance emphasises that vaping can perpetuate nicotine dependence and that population-level harms (particularly among young people) remain a major concern.

Practical interpretation for users

“Less harmful” is not the same as “safe.” Vaping typically removes combustion and many tobacco-smoke toxicants, which plausibly reduces some risks compared with continuing to smoke. But vaping still delivers nicotine (addictive) and other chemicals, and inhalation of heated aerosols has uncertain long-term effects.

Device and liquid matter. Risk varies by product quality, formulation, presence of contaminants, and user behaviour. That’s one reason regulators now restrict sales pathways and product standards in Australia — to reduce unsafe products and unknown exposures.

Context matters. For a long-term smoker unable to quit with licensed therapies, switching completely to regulated nicotine-containing vaping products under clinical supervision may reduce exposure to some toxicants. For young people or never-smokers, initiation of vaping is an avoidable health risk and public-health concern.

Why exact percentages (like 95%) mislead

A single percentage disguises many uncertainties: differences in devices, user patterns, nicotine strengths, contaminants, and which health outcomes are counted. The original 95% estimate was useful as an impression that vaping likely posed substantially fewer of the classic combustion-related harms than smoking — but it was never a precise scientific measurement of all risks. Later commentary explicitly warns against repeating the figure without context.

Bottom line — what a practical reader should take away

Vaping is probably less harmful than continuing to smoke combustible cigarettes for many smokers, but the exact degree of reduced harm cannot be stated confidently as a single number such as “95%.”

If you smoke and cannot quit with first-line treatments, discussing regulated options (including clinically supported nicotine-replacement therapies or therapeutic vaping products where lawful) with a clinician may be reasonable; self-switching to unregulated disposables has legal and safety issues in Australia.

If you do not smoke, do not start vaping. Initiation introduces nicotine dependence and uncertain long-term lung and cardiovascular risks.

Final note on products and regulation

Mentions of brands such as alibarbar vape or the category disposable vapes Australia appear frequently in retail contexts, but regulatory changes in Australia (since 2024) have substantially restricted commercial supply and tightened product standards. That policy shift reflects both health caution and the current limits of long-term evidence.